The Longevity Fund

San Francisco, California
A $37 million fund investing in seed and Series A stages for startups pursuing therapeutic breakthroughs targeting age-related diseases.

Fund scope

Investment criteria breakdown.
Investment stages
Pre-Seed
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$0 - $100K
$100K - $500K
$500K - $1M
Focus areas
Biotech
Deeptech

Related unicorns

A glimpse at some of the $1B+ valuation companies backed by this fund.

Partners

Fund leadership and team.
Laura Deming
Founder and General Partner
View profile

Related Sector Funds

Funds investing in similar industries.
+ND Capital Fund)
Cayman Islands
Seed
Series A
Series B+
11.2 Capital
San Francisco, California
Pre-Seed
Seed
Series A
Series B+
1955 Capital
San Francisco, California
Pre-Seed
Seed
25M Health
New York, New York
Pre-Seed
Seed
3CC | Third Culture Capital
Boston, Massachusetts
Pre-Seed
Seed
Series A
5AM Ventures
San Francisco, California
Seed
Series A

Browse more categories